JP6669734B2 - ピラゾリル−３，４−ジドヒドロキノリン−２−オン・アルドステロン合成酵素阻害剤 - Google Patents

ピラゾリル−３，４−ジドヒドロキノリン−２−オン・アルドステロン合成酵素阻害剤 Download PDF

Info

Publication number
JP6669734B2
JP6669734B2 JP2017515897A JP2017515897A JP6669734B2 JP 6669734 B2 JP6669734 B2 JP 6669734B2 JP 2017515897 A JP2017515897 A JP 2017515897A JP 2017515897 A JP2017515897 A JP 2017515897A JP 6669734 B2 JP6669734 B2 JP 6669734B2
Authority
JP
Japan
Prior art keywords
methyl
pyrazol
dihydroquinolin
fluoro
carbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017515897A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017537056A (ja
JP2017537056A5 (https=
Inventor
エービ，ヨハネス
アムライン，クルト
ホルンスペルガー，ブノワ
クーン，ベルント
リウ，ヨンフゥ
メルキ，ハンス・ペー
マルティン，ライナー・エー
マイヴェーク，アレクサンダー・ファオ
タン，スーフェイ
ワン，リーシャ
リ，ドンボ
ウー，ジュン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JP2017537056A publication Critical patent/JP2017537056A/ja
Publication of JP2017537056A5 publication Critical patent/JP2017537056A5/ja
Application granted granted Critical
Publication of JP6669734B2 publication Critical patent/JP6669734B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2017515897A 2014-10-31 2015-10-28 ピラゾリル−３，４−ジドヒドロキノリン−２−オン・アルドステロン合成酵素阻害剤 Active JP6669734B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2014090064 2014-10-31
CNPCT/CN2014/090064 2014-10-31
PCT/EP2015/074923 WO2016066663A1 (en) 2014-10-31 2015-10-28 Pyrazolyl-3,4-dihydroquinolin-2-one aldosterone synthase inhibitors

Publications (3)

Publication Number Publication Date
JP2017537056A JP2017537056A (ja) 2017-12-14
JP2017537056A5 JP2017537056A5 (https=) 2018-12-06
JP6669734B2 true JP6669734B2 (ja) 2020-03-18

Family

ID=54356342

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017515897A Active JP6669734B2 (ja) 2014-10-31 2015-10-28 ピラゾリル−３，４−ジドヒドロキノリン−２−オン・アルドステロン合成酵素阻害剤

Country Status (5)

Country Link
US (1) US9796702B2 (https=)
EP (1) EP3212631B1 (https=)
JP (1) JP6669734B2 (https=)
CN (1) CN106660998B (https=)
WO (1) WO2016066663A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739338A (en) * 1996-11-05 1998-04-14 Allergan N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity
DE102008022221A1 (de) * 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
TWI462914B (zh) * 2011-09-15 2014-12-01 Hoffmann La Roche 新穎二氫喹啉－２－酮衍生物
US9353081B2 (en) * 2011-09-23 2016-05-31 Hoffmann-La Roche Inc. Bicyclic dihydroquinoline-2-one derivatives
WO2014135561A1 (en) * 2013-03-08 2014-09-12 F. Hoffmann-La Roche Ag New dihydroquinoline-2-one derivatives as aldosterone synthase (cyp1 1 b2 or cyp1 1 b1 ) inhibitors
RU2015138961A (ru) * 2013-03-14 2017-04-18 Ф. Хоффманн-Ля Рош Аг Производные дигидрохинолин-2-она для применения в качестве ингибиторов альдостеронсинтазы

Also Published As

Publication number Publication date
JP2017537056A (ja) 2017-12-14
EP3212631A1 (en) 2017-09-06
EP3212631B1 (en) 2020-02-12
WO2016066663A1 (en) 2016-05-06
US20170226085A1 (en) 2017-08-10
CN106660998B (zh) 2019-10-25
US9796702B2 (en) 2017-10-24
CN106660998A (zh) 2017-05-10

Similar Documents

Publication Publication Date Title
JP6581970B2 (ja) 新規３，４−ジヒドロ−２ｈ−イソキノリン−１−オン及び２，３−ジヒドロ−イソインドール−１−オン化合物
JP6574705B2 (ja) アルドステロン合成酵素（ｃｙｐ１１ｂ２又はｃｙｐ１１ｂ１）阻害剤としての新規ジヒドロキノリン−２−オン誘導体
JP2019014738A (ja) 新規３，４−ジヒドロ−２ｈ−イソキノリン−１−オン及び２，３−ジヒドロ−イソインドール−１−オン化合物
JP2016537325A (ja) アルドステロン合成酵素阻害剤としての新規フェニルジヒドロピリジン誘導体
JP6117948B2 (ja) アルドステロン合成酵素阻害薬としての使用のためのジヒドロキノリン−２−オン誘導体
JP6670832B2 (ja) アルドステロン合成酵素阻害剤としての新規ジヒドロキノリンピラゾリル化合物
JP6669734B2 (ja) ピラゾリル−３，４−ジドヒドロキノリン−２−オン・アルドステロン合成酵素阻害剤
JP6626885B2 (ja) 新しいピリジニルオキシ及びフェニルオキシピラゾリル化合物
JP6622300B2 (ja) 新規なジヒドロキノリンピラゾリル化合物
HK1232542B (zh) 吡唑基-3，4-二氢喹啉-2-酮醛固酮合酶抑制剂
HK1232542A1 (en) Pyrazolyl-3,4-dihydroquinolin-2-one aldosterone synthase inhibitors
HK1232215B (zh) 作为醛固酮合酶抑制剂的新型二氢喹啉吡唑基化合物
HK1232887B (zh) 新型二氢喹啉吡唑基化合物
HK1232887A1 (en) New dihydroquinoline pyrazolyl compounds

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181024

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20181024

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190723

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20190725

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190926

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200110

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20200204

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200227

R150 Certificate of patent or registration of utility model

Ref document number: 6669734

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250